nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site
|
Martyn, Gabriella E. |
|
|
133 |
8 |
p. 852-856 |
artikel |
2 |
A novel RAG1 mutation reveals a critical in vivo role for HMGB1/2 during V(D)J recombination
|
Thwaites, Daniel T. |
|
|
133 |
8 |
p. 820-829 |
artikel |
3 |
Arterial thromboembolic events preceding the diagnosis of cancer in older persons
|
Navi, Babak B. |
|
|
133 |
8 |
p. 781-789 |
artikel |
4 |
A silent response to silent thrombosis
|
O'Brien, Sarah |
|
|
133 |
8 |
p. 776-777 |
artikel |
5 |
BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis
|
Yu, Shanshan |
|
|
133 |
8 |
p. 805-815 |
artikel |
6 |
B-cell lymphomas present immunoglobulin neoantigens
|
Khodadoust, Michael S. |
|
|
133 |
8 |
p. 878-881 |
artikel |
7 |
CVC-related thrombosis in critically ill children
|
|
|
|
133 |
8 |
p. 884 |
artikel |
8 |
Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation
|
Camargo, Jose F. |
|
|
133 |
8 |
p. 867-877 |
artikel |
9 |
Directing the conductor: TNF regulation of HSCs
|
Nutt, Stephen L. |
|
|
133 |
8 |
p. 771-773 |
artikel |
10 |
Editorial Board
|
|
|
|
133 |
8 |
p. i |
artikel |
11 |
FBXW7 is a biologically validated cancer driver gene for CLL
|
Rossi, Davide |
|
|
133 |
8 |
p. 774-776 |
artikel |
12 |
FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLL
|
Close, Viola |
|
|
133 |
8 |
p. 830-839 |
artikel |
13 |
Fibrin-associated diffuse large B-cell lymphoma confined to a cardiac myxoma
|
Garces, Sofia |
|
|
133 |
8 |
p. 882 |
artikel |
14 |
How I treat low von Willebrand factor levels
|
Lavin, Michelle |
|
|
133 |
8 |
p. 795-804 |
artikel |
15 |
If Trousseau had a stroke
|
Khorana, Alok A. |
|
|
133 |
8 |
p. 769-770 |
artikel |
16 |
Inflammatory signals directly instruct PU.1 in HSCs via TNF
|
Etzrodt, Martin |
|
|
133 |
8 |
p. 816-819 |
artikel |
17 |
Luspatercept for the treatment of anemia in myelodysplastic syndromes and primary myelofibrosis
|
Fenaux, Pierre |
|
|
133 |
8 |
p. 790-794 |
artikel |
18 |
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
|
Schlenk, Richard F. |
|
|
133 |
8 |
p. 840-851 |
artikel |
19 |
“Myelodysplasia” from copper deficiency
|
Siddiqui, Salahuddin |
|
|
133 |
8 |
p. 883 |
artikel |
20 |
RAGs usurp cellular factors for both breaking and repairing
|
Meek, Katheryn |
|
|
133 |
8 |
p. 773-774 |
artikel |
21 |
Splicing up hematopoietic development
|
de Jong, Jill L.O. |
|
|
133 |
8 |
p. 770-771 |
artikel |
22 |
The natural history of asymptomatic central venous catheter–related thrombosis in critically ill children
|
Jones, Sophie |
|
|
133 |
8 |
p. 857-866 |
artikel |
23 |
T'ing off on posttransplant CMV
|
Auletta, Jeffery J. |
|
|
133 |
8 |
p. 777-779 |
artikel |